Category: Marco Blog

[Webinar Recording] Continuing the Discussion: The latest in diagnosis and treatment options for dry eye and peri-ocular inflammatory disease

We continue the discussion on Dry Eye with Dr. Paul Karpecki, Associate Professor UPike College of Optometry/Kentucky Eye Institute.

Topics Include:
– Clinical details of LLLT technology
– Case sudies
– If/when the use of IPL technology is recommended

Session 3 in the Dry Eye Workshop Series

To view Dry Eye webinar Part 1, click here
To view Dry Eye webinar Part 2, click here

Request more information about Dry Eye technologies from Marco →

Filed under: Marco Blog

Marco Enters United States Distribution Agreement with Olleyes, Inc.

Advancing Eyecare Company, Marco Ophthalmic, Announces VisuALL S Virtual Reality Visual Field Analyzer as New Addition to Product Portfolio

Jacksonville, Florida, June 24, 2021 – Marco Ophthalmic, a leading ophthalmic technology company, has entered into a distribution agreement with Olleyes, Inc., who offers intuitive and easy-to-use virtual reality ophthalmic products. Effective immediately, Marco, will add the Olleyes VisuALL S VRP® (Virtual reality Platform) into their existing portfolio of ophthalmic medical devices. 

The VisuALL is the latest commercially-available virtual reality visual field analyzer that can be used in clinical practice to detect glaucoma and to evaluate other eye diseases.

“The VisuALL is a multi-testing Virtual Reality Platform that increases doctors’ efficiencies. The platform brings several advantages over current technologies. Our alliance with Marco will help more clinicians and patients benefit from the VisuALL throughout the United States.” said Alberto Gonzalez-Garcia MD, CEO of Olleyes.

Glaucoma is the most common cause of irreversible blindness[i]. Based on prevalence studies, it is estimated that 79.6 million individuals had glaucoma by 2020, and this number is likely to increase to 111.8 million individuals in 2040[ii]. In many cases, glaucoma may be asymptomatic. Unfortunately, many individuals are unaware of the existence of glaucoma and as many as half of those with glaucoma are unaware that they are affected[iii].

In many cases, blindness can be prevented with appropriate control and treatment, and the VisuALL can help with early detection of these diseases.

“Marco is one of the largest and most respected suppliers of ophthalmic equipment and medical devices in the country, and Olleyes is extremely excited to enter into this distribution partnership,” said Armond Dantino, VP of Business Development of Olleyes. “By expanding our distribution network throughout the United States, the VisuAll S VRP has potential to reach an additional 200 million people.  Partnering with the Marco team helps Olleyes to realize our company’s vision of providing a comfortable, accurate, reliable, and cost-effective solution for administering visual diagnostics.”

Jocelyn Hamilton, Head of Sales and Vice President/General Manager for Marco Ophthalmic, commented, “We are rapidly executing our innovation pipeline and building a full suite of products in the ophthalmic technology space. Our approach to fulfilling market needs in this ever-changing environment has been very strategic and we are excited to partner with Olleyes to promote and distribute the VisuALL to eyecare professionals nationwide.”

To get more information about the VisuALL go to marco.com/product/olleyes-visuall-vrp.

 

About Advancing Eyecare

Advancing Eyecare™ is a partnership of leaders in the eyecare instrumentation marketplace established to offer the best products and service solutions in the ophthalmic equipment industry. Currently comprised of Marco Ophthalmic, Lombart Instrument, Enhanced Medical Services (EMS), Ophthalmic Instruments, Inc., S4OPTIK, and INNOVA Medical, the combined scope of the organization has the broadest product portfolio, the most knowledgeable people, and the most reliable service in the industry. Visit www.advancingeyecare.com for more information.

About Marco Ophthalmic

As the Leader in Vision Diagnostics®, Marco continues to revolutionize the ophthalmic industry with a full suite of automated refractive and diagnostic devices as well as a broad range of high-end classic exam lane equipment. Marco is a member of the Advancing Eyecare Alliance. Visit www.marco.com for more information.

About Olleyes

Olleyes, Inc. equips eye care professionals with the instrument, tools, and education needed to effectively diagnose and treat patients with glaucoma and other diseases of the eye. Olleyes was created by a visionary neuro-ophthalmologist and a group of professionals who saw the necessity of making eye-care accessible and personalized. The company makes intuitive and easy to use products, equipped with artificial intelligence, virtual reality (VR), eye tracking and proprietary algorithms to make the eye evaluation faster and more reliable. Visit www.olleyes.com for additional information.

Media Contact:

Chris Tofalli
Chris Tofalli Public Relations, LLC
914-834-4334

  • [ii] “Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040”, Ophthalmology 2014; 121:2081-2090
  • [iii] Quigley, H. A., Broman, A. T., “The number of people with glaucoma worldwide in 2010 and 2020,” British Journal of Ophthalmology (2006); 90:262–267. doi: 10.1136/bjo.2005.081224
    • Friedman, David S., Roger C.W. Wolfs, Benita J. O’Colmain, Barbara E. Klein, Hugh R. Taylor, Sheila West, M. Cristina Leske, Paul Mitchell, Nathan G. Congdon, and John Kempen. “Prevalence of Open-Angle Glaucoma Among Adults in the United States“. Archives of Ophthalmology. 2004 Vol. 122, No. 4, pp. 532-8
    • Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma: the Baltimore Eye Survey. JAMA. 1991;266:369–374
    • Wensor MD, McCarty CA, Stanislavsky YL, Livingston PM, Taylor HR. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology. 1998;105:733–739

 

Filed under: Marco BlogTagged with: ,

The Critical Role of Patient Education in Dry Eye Treatment

Low-Level Light Therapy

by Paul Karpecki, OD, FAAO

Positive outcomes for dry eye patients depend greatly on their participation in their own health decisions, and they can make the best choices with appropriate guidance and recommendations from their doctor. But what is the best way to educate these patients about their condition and treatment options?

The ideal approach for patient education is a three-step process: 

Identification: First, clearly identify and explain the condition for the patient.  A picture is ideal and as the adage says, “worth a thousand words”. 

Pathology: Next, with a picture up on a slit lamp imaging system, magnified on an iPhone, or via animations, point out the area of pathology and let them know what is concerning.  If something is concerning to the doctor, it is concerning to the patient as well.  For example, you can point out the erythema, blepharitis, or telangiectatic vessels on the eyelid margin. 

Significance: Lastly, discuss the benefits to the patient as well as the consequences of not treating such as loss or atrophy of meibomian glands, inability to wear contact lenses, thinning or loss of lashes, and the potential for chronic dry eye disease.

Remember that empathy and enthusiasm are important components for patient buy-in.  Dry eye patients have often been dealing with their symptoms for a long time.  Showing that their situation is a significant concern to all provides confidence in you and your recommended treatment plan as does your enthusiasm for the procedure and its potential to help the patient.

Once the patient is fully educated about their condition and treatment options, they can make an informed decision based on their economic situation and their desire to be compliant with at home treatments versus in-office procedures. 

Many patients appreciate the dental model, with a more targeted in-office procedure such as Low-Level Light Therapy (LLLT) followed by at home maintenance.  Although insurance does not cover these in-office procedures, their efficacy and the hope of slowing the already extensive gland loss often outweighs the cost.

The combination of highly-effective therapies such as LLLT and the right education model can result in superior dry eye management and more satisfied patients.  Just remember the three E’s: Education, Empathy, and Enthusiasm.

Learn more about dry eye technologies from Marco →

Filed under: Marco Blog

[Webinar Recording] Navigating your way through Low-Level Light Therapy (LLLT) for Dry Eye-MGD Treatment

Have you recently purchased or are you looking to add LLLT technology to your practice? This interactive workshop helps you understand this new technology and how to effectively integrate it into your practice.  Presented by Dr. Paul Karpecki, Associate Professor UPike College of Optometry/Kentucky Eye Institute.

Topics Include:
– Treatment Protocols
– Contraindications (or lack there-of)
– The deep science
– LED wavelengths, efficacy, and more

Session 2 in the Dry Eye Workshop Series

To view Dry Eye webinar Part 1, click here
To view Dry Eye webinar Part 3, click here

Request more information about Dry Eye technologies from Marco →

Filed under: Marco Blog

Low Level Light Therapy: Using the Marco Equinox to Treat Dry Eye and Chalazion

Original Article Published on Eyes On Eyecare.
Eyes On Eyecare Article

Meibomian gland dysfunction involves the thickening and obstruction of meibum in their glands, and is one of the most common causes of dry eye.  This article covers how Low level light therapy (LLLT) offers an inexpensive and effective treatment option for many patients.

Read the full article by Bruce Colton, OD here.

Filed under: Marco BlogTagged with: , , ,

[Webinar Recording] Dry Eye Excellence – A Discussion of the Latest Dry Eye Therapy

This interactive workshop will help you understand the latest in Dry Eye technology and how to effectively integrate it into your practice. Dr. Karpecki is a pioneer in using photobiomodulation technology in the United States so don’t miss out on this opportunity to hear his insights.

Session 1 in the Dry Eye Workshop Series

To view Dry Eye webinar Part 2, click here
To view Dry Eye webinar Part 3, click here

Request more information about Dry Eye technologies from Marco →

Filed under: Marco Blog

Spend Money To Make Money – An Article From Women in Optometry

Original Article Published in Women in Optometry

Shonda Achord, OD, of Achord Eye Clinic in Baton Rouge, Louisiana, hasn’t looked back since switching to the Marco Diagnostic Solutions TRS Refraction System. While she had already outgrown paper charts, she still found the switch expedited the whole process. “I can’t imagine the practice without it,” she says. The five-lane practice has a TRS in two lanes where Dr. Achord works, and her associates use the other lanes but can rotate through these two in her absence.

When she first brought in the TRS Refraction System, she found the refraction process to be so much faster that she felt her whole day could be restructured. “I felt like I could do four to five more exams per day—even before I added the OPD-Scan III wavefront aberrometer,” she says. “It’s just that efficient.” She has also found that with great technology comes a great reputation. “Patients were really impressed with it… so all that plays into the practice’s reputation. The wow factor is present, too. Patients always comment on it.”

GROWING, GROWING, GROWN
Part of Dr. Achord’s growth is attributed to an expansion she undertook. “I went from 1,600 square feet to 3,750 square feet, and I already wish I had more space,” she says. The practice has three doctors—Dr. Achord and two associates. While there are only two of them at a time there daily, the five exam lanes plus workup room/exam lane are always in use. She has seen a major change in patient flow already, with 30 percent of her patients currently being new to the practice. “I couldn’t do that before because we didn’t have the space or capacity for more patients,” she says. Despite her initial reluctance to move to a larger space, the lesson is the same one she passes on to doctors about equipment and technology: “If you don’t spend money, you won’t make more.”

“When I first added Marco technology, growth was the point,” she says. “Being able to fit in more patients and do it well was what I wanted. Now my goal is efficiency. I’m not trying to see a huge number of patients per day, but it frees up time that I can use in conversation and communication.”

Patients prefer it, too. “Refractions make people nervous,” says Dr. Achord. “When I have to dial it into a manual phoropter, it’s not as impressive as showing them their earlier prescription and the new one with the push of a button.” She has found that patients being able to see the differences for themselves has translated into the sale of more eyewear. “I didn’t like being the one to say, ‘Well, it changed this much so you should get new eyeglasses.’ If the Rx change didn’t make enough of a difference to them but I had told them they should buy new eyewear, then they may not trust me as much.” With the new system, Dr. Achord and her associates are able to let the patient decide for themselves with all the information in hand. Dr. Achord also has found few to no transcription errors, which has led to fewer remakes of eyeglasses.

The new system has proven to be useful in making up for closings and reduced volume during the pandemic. “We want to get patients in and out as fast as we can,” she says. At the same time, “We have to see people and catch up for the time we were closed, so we have to be efficient.” When it comes to the OPD, Dr. Achord praises its efficiency in helping her assess the issue. “It gives us topography, so right away I can see if there’s a reason that the patient might not achieve 20/20,” she says. “It’s an amazing instrument, and it saves me and the patient time and frustration.” She finds that the more information she has, the better she can advise the patient moving forward. “I can explain that the topography shows what issues we can’t overcome easily and what the options and/or compromises might be.”

She’s happy to share with her colleagues inside and outside of the Vision Source network how much more efficient the Marco technology has made her practice, and she emphasizes how even small time-savings with each patient add up. “I feel like if you don’t invest back in the practice, it’s not going to be successful.”

Ergonomic Benefits
For herself and her future well-being, Dr. Shonda Achord is also thankful she added the TRS Refraction System. “I’m only 5’3”, and I would rest my wrists and hands on the top of the manual phoropter because my arms got so tired,” she says. “I developed pleurisy, and it would hurt to breathe. My doctor asked if I did exercises that kept my arms and shoulders up—but it was my work.” She also notes that the new autorefraction system allows her to sit more throughout the day rather than standing all day like she was before. Another perk? “In the days of pandemic and flu, I’m five to six feet away from people,” using the tabletop controller.

Filed under: Marco BlogTagged with: , , ,

How One Doctor is Seeing Results with the Marco Equinox

How One Doctor is Seeing Results with the Marco Equinox

Bruce Colton, OD shares his experiences with Dry Eye treatment using the Marco Equinox. The following are true patient cases and his patients are ecstatic over the results.

“I have a staff member with severe chronic dry eye associated with autoimmune diseases. She has had superficial keratitis every day for many years. Working for other optometrists over the last five years she has tried hot compresses, restasis, bandage lenses, punctal plugs, omega 3 vitamins, doxycycline, everything. I put an amnion on her which reduced her keratitis for a few days and then it came right back. The best acuity I could ever get her to was 20/40. I was given the Marco Equinox to use for a few days, and did a single 15-minute treatment on her. The next morning she said was the first time in years she has woken up without her eyes hurting or eyelids sticking to her cornea. She felt great, and a few days later I refracted her to 20/20. She still has a chronic condition which we have to manage, but the Marco Equinox light therapy has made a bigger difference for her than all previous treatments combined.” 

“I have a male patient in his 50’s who has suffered from severe chronic dry eye for over a decade. He has been to many optometrists and ophthalmologists and followed all of their recommendations, which never offered more than very short term relief. He was paying hundreds of dollars a month for Restasis and Xiidra, hoping for a relief which never came. He carried a bottle of lubricant and used it every hour or two throughout each day. When I first took over his care I did not have the Marco Equinox technology. I used hot compresses, manually expressed his glands, which were rock hard, and put him on doxycycline. After a few months he felt 30% better, but was still using lubricant drops every two hours. When I got the Marco Equinox I immediately thought of him and called him in to do three 15-minute sessions and no other treatments. A month later all of his meibomian glands easily expressed a very high quality and quantity of oil, and he had completely stopped using his lubricant because he had no symptoms for the first time in over a decade.” 

“I had a 6-year-old hispanic boy come to me with two huge chalazions on his right lower lid that had been there for months. They did not hurt, but they looked horrible, the size of marbles. He had already done hot compresses at the recommendation of his pediatrician, with no improvement. The mom was concerned because he would get a new chalazion every 6 months and it would have to be surgically removed. Every surgery would scar up a few meibomian glands that he could never get back. His long term prognosis for chronic ocular surface disease was very bleak. I gave him a 15-minute Marco Equinox treatment. A week later, the largest chalazion was 70% smaller. I couldn’t believe my eyes. We did another 15-minute treatment. A week later, the largest chalazion was 90% gone and the second chalazion was 50% gone. Of course, all of his other meibomian glands were now cleanly flowing. You can see where this is going. With two more treatments we got him to complete chalazion resolution, restored his gland function so he does not get any more chalazion in the future, and saved him the dangers of general anesthesia and excessive surgical destruction of all of his meibomian glands. I did this all with no drugs. No surgery. No high price tag. No risk. That is the Marco Equinox.”

View Dr. Colton’s video below on Meibomian Gland Disease/Dysfunction.

Bruce Colton, OD - Bright Eyes Vision Clinic - Murphy, TX

The Latest Dry Eye Technology Exclusively from Marco

View Phoenix Meibography Workstation
View Equinox Low Level Light Therapy
Filed under: Marco Blog